.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Daiichi Sankyo
Colorcon
US Department of Justice
Fish and Richardson
Boehringer Ingelheim
Cerilliant
Johnson and Johnson
Teva

Generated: November 18, 2017

DrugPatentWatch Database Preview

Physiological Effect: Neuromuscular Nondepolarizing Blockade

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nanjing King-friend
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION091489-001Feb 17, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION090761-001Oct 18, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION206096-001Jun 22, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION206011-001Apr 8, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
ATRACURIUM BESYLATE PRESERVATIVE FREE
atracurium besylate
INJECTABLE;INJECTION090782-001Oct 18, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Nanjing King-friend
ATRACURIUM BESYLATE PRESERVATIVE FREE
atracurium besylate
INJECTABLE;INJECTION091488-001Feb 17, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ATRACURIUM BESYLATE PRESERVATIVE FREE
atracurium besylate
INJECTABLE;INJECTION206010-001Apr 8, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
ATRACURIUM BESYLATE PRESERVATIVE FREE
atracurium besylate
INJECTABLE;INJECTION206001-001Apr 7, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui Med
CISATRACURIUM BESYLATE
cisatracurium besylate
INJECTABLE;INJECTION209334-001Aug 30, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
CISATRACURIUM BESYLATE
cisatracurium besylate
INJECTABLE;INJECTION203183-001Feb 26, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Citi
Johnson and Johnson
US Army
US Department of Justice
McKinsey
Federal Trade Commission
Cipla
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot